Treponema denticola has been recognized as an important oral pathogen of the "red complex" bacterial consortium that is associated with the pathogenesis of endodontal and periodontal diseases. However, little is known about the virulence of T. denticola due to its recalcitrant genetic system. The difficulty in genetically manipulating oral spirochetes is partially due to the lack of antibiotic resistance cassettes that are useful for gene complementation following allelic replacement mutagenesis. In this study, a kanamycin resistance cassette was identified and developed for the genetic manipulation of T. denticola ATCC 35405. Compared to the widely used ermF-ermAM cassette, the kanamycin cassette used in the transformation experiments gave rise to additional antibiotic-resistant T. denticola colonies. The kanamycin cassette is effective for allelic replacement mutagenesis as demonstrated by inactivation of two open reading frames of T. denticola, TDE1430 and TDE0911. In addition, the cassette is also functional in trans-chromosomal complementation. This was determined by functional rescue of a periplasmic flagellum (PF)-deficient mutant that had the flgE gene coding for PF hook protein inactivated. The integration of the full-length flgE gene into the genome of the flgE mutant rescued all of the defects associated with the flgE mutant that included the lack of PF filament and spirochetal motility. Taken together, we demonstrate that the kanamycin resistance gene is a suitable cassette for the genetic manipulation of T. denticola that will facilitate the characterization of virulence factors attributed to this important oral pathogen.
T reponema denticola, a Gram-negative, spiral-shaped, obligate anaerobe, is a virulent and invasive spirochete that is associated with advanced periodontal disease (1) (2) (3) . In addition, T. denticola, along with other "red complex" bacteria, contributes to endodontal infection both in humans and in experimental animals (4-6). Although T. denticola primarily cause infections of the oral cavity, they have also been associated with the development of cardiovascular disease (7) (8) (9) (10) and other systemic conditions (11, 12) . A number of putative pathogenic attributes that include: the establishment of a stable biofilm, invasive motility, and the production of various proteases and toxins, have been studied in vitro (4, (13) (14) (15) (16) . Moreover, the use of animal models (17) have revealed additional insight into their pathogenesis (14, (18) (19) (20) (21) (22) . Efforts to further our understanding of T. denticola biology have been impeded by the fastidious nature and specific genetic restriction modification system of this oral spirochete, particularly in the widely used strain T. denticola ATCC 35405, which has a sequenced and fully annotated genome (23, 24, 25) .
Several attempts have been made to develop a reproducible genetic system to study T. denticola (26) (27) (28) (29) . The ermF-ermAM cassette, originally developed for the mutagenesis of another oral pathogen Porphyromonas gingivalis (27) , has frequently been used as a selective marker to inactivate T. denticola genes (30) (31) (32) (33) . The ermF-ermAM cassette conferred erythromycin resistance in both Escherichia coli and T. denticola (27, 34) . Recently, a simplified ermAM cassette has been shown to be effective in the mutagenesis of T. denticola (34) . In addition, coumermycin and chloramphenicol cassettes have been used in a different strain, T. denticola ATCC 33520, for the transformation of shuttle plasmids that generally do not replicate in T. denticola 35405. Only erythromycin and gentamicin cassettes have been suitable for the manipulation of the sequenced and annotated strain, T. denticola 35405 (29, 35, 36) . The development of a reliable antibiotic cassette is essential for the genetic study of this important oral pathogen since complementation has been problematic.
We screened a variety of antibiotic resistance cassettes and found a kanamycin resistance gene that is a reliable selective marker for T. denticola 35405 and demonstrated the utility of a kanamycin resistance cassette in the mutagenesis of T. denticola genes. Furthermore, we provided evidence this cassette can be used in the complementation of a nonmotile flgE mutant resulting in a fully restored periplasmic flagellum (PF), enabling a motile phenotype (37) .
MATERIALS AND METHODS
Culture and growth conditions of T. denticola. T. denticola ATCC 35405 (American Type Culture Collection, Manassas, VA) cells were inoculated in new spirochete medium (NOS) supplemented with 10% heat-inactivated rabbit serum and incubated at 35°C in an anaerobic chamber (Coy Laboratory Products, Inc., Ann Arbor, MI) with an atmosphere of 80% nitrogen, 10% carbon dioxide, and 10% hydrogen (38) .
DNA manipulation and construction of plasmids. T. denticola genomic DNA was extracted by using an UltraClean microbial DNA isolation kit (catalog no. 12224-50; MO BIO Laboratories, Inc., Carlsbad, CA). All PCR products were amplified by using GoTaq Green master mix (Promega, Madison, WI) except where specifically noted. All primers used were listed in Table 1 and synthesized by Sigma-Aldrich with normal desalting purification. Plasmids and PCR products were purified by using a QIAprep spin miniprep kit and a QIAquick gel extraction kit (Qiagen, Inc., Valencia, CA), respectively. Larger-scale plasmid purification was conducted using the HiPure plasmid midiprep kit (Invitrogen, San Diego, CA). All restriction digestion enzymes were purchased from Promega. DNA sequence validation of various plasmid constructs were performed by the DNA sequencing facility at Genomics Core Laboratories, The University of Alabama at Birmingham, Birmingham, AL.
All plasmids and strains constructed in the present study are listed in Table 2 . Experimental procedures used to construct each plasmid and bacterial strain are described below. The ErmF promoter was used to drive the expression of different antibiotic cassettes that were cloned into a pGEM-T vector. In brief, the ErmF promoter (P1) was PCR amplified by using the primer set of Promoter1-KpnI-BamHI-F and Promoter1-AgeIXhoI-XbaI-R and cloned into the pGEM-T vector at the XbaI and SpeI sites of the pGEM-T vector. Various antibiotic resistance genes (ARGs) were subsequently ligated into this plasmid backbone using two restriction enzyme sites, AgeI and XhoI, to generate constructs harboring different antibiotic resistance cassettes, including two kanamycin resistance genes (aphA1 [GenBank accession no. NP_478154] and aphA2 [GenBank accession WP_004614937]; Clontech Laboratories, Inc., Mountain View, CA), a chloramphenicol acetyltransferase gene (cat [GenBank accession no. NP_052903]), and a gentamicin resistance gene (gat [GenBank accession no. P23181] synthesized by GenScript [Piscataway, NJ]; the sequence was optimized according to T. denticola 35405 codon usage), respectively (plasmids I, II, III, and IV; see Table 2 and Fig. 1A ).
An allelic replacement mutagenesis scheme was used to inactivate genes of interest. The TDE1430 gene was partially deleted and replaced with an appropriate antibiotic resistance gene. In brief, a 4.0-kb fragment containing the full-length TDE1430 gene (1,008 bp) and 5= (1,570 bp) and 3= (1,423 bp) flanking regions of the DNA fragment of TDE1430 was PCR amplified using TDE1430-F1 and TDE1430-R1 primers and ligated into pGEM-T Easy to construct pGEM-T Easy-TDE1430 (plasmid V). This plasmid was used as a template in an inverse PCR with the primer pair TDE1430-BamHI-R and TDE1430-XhoI-F to partially delete TDE1430 from amino acid residues 1 to 270 to generate a 6.2-kb inverse PCR product. This construct was then ligated with different antibiotic resistance cassettes, specifically, ermF-ermAM, P1aphA1, P1aphA2, P1cat, and P1gat using the BamHI and XhoI sites (Fig. 1A) in the place of the partially deleted TDE1430 to generate TDE1430 mutant alleles that were replaced with various antibiotic resistance genes (plasmids VI, VII, VIII, IX, and X; Table 2 ).
To insert a kanamycin resistance gene without a linked promoter into TDE1430 to construct an in-frame fusion of aphA2 with the remaining TDE1430, an inverse PCR was first performed to partially delete TDE1430. Plasmid V was used as a template, and the primer pair TDE1430-AgeI-R and TDE1430-XhoI-F depicted in Fig. 1A was used in the inverse PCR. The inverse PCR product obtained was then ligated with aphA2 by AgeI and XhoI sites to generate plasmid XI (Fig. 1B) .
In-frame deletion of TDE0911 was carried out as follows. In brief, the 5=-flanking region (483 bp) of TDE0911 was amplified and ligated with pGEM-T easy at the XhoI and SpeI restriction sites of pGEM-T Easy. The aphA2 was subsequently cloned downstream of this 483-bp fragment at the AgeI and XhoI restriction sites and then ligated with the 3=-flanking region (1,277 bp) of TDE0911 via XhoI and SpeI sites to generate plasmid XII (Fig. 1C) .
Complementation of the flgE mutant was performed by integrating the full-length flgE gene driven by the promoter from the fla operon (P2) (39) into the TDE1430 locus. In brief, the P2 promoter was ligated into 3= end of the aphA2 using the XhoI and XbaI sites (Fig. 1D) , followed by addition of the flgE gene using the XbaI and SalI sites. This integration construct was then released from the pGEM-T vector by restriction digestion using BamHI and SalI, which was then used to replace TDE1430 (1 to 270 amino acid residues) from the plasmid V (Fig. 1A) to generate an integration plasmid (XIII) (Fig. 1D ). This step was completed by ligation of the BamHI-and SalI-digested integration construct with the inverse PCR product obtained using plasmid V as a template and the primer pair of TDE1430-BamHI-R and TDE1430-XhoI-F (Fig. 1A) . All of these plasmid constructs were confirmed by restriction digestion and DNA sequencing. Constructs used for transformation were then released and linearized by NotI from the corresponding plasmids prior to introduction into T. denticola. Transformation of T. denticola. Transformation of T. denticola was conducted as previously described (40, 41) . Briefly, 15-g portions of the various DNA constructs were added to 100 l of competent cells, followed by incubation on ice for 30 min, followed in turn by electroporation at 1.8 kV, 200 ⍀, and 25 F in a 1-mm cuvette (the observed voltages were between 1,787 and 1,786 V, while the time constant remained at 5.1 ms). The transformation mixture resuspended in 1.5 ml of NOS was transferred to an anaerobic chamber to allow electroporated bacteria to grow overnight at 35°C. Ninety percent of the overnight culture was mixed with 4 ml of prewarmed 3% SeaPlaque low-melting-temperature agarose (Lonza, Rockland, ME), and added to 24.5 ml of prewarmed NOS (37°C) that contained different antibiotics (kanamycin [25 g/ml] or erythromycin [40 g/ml]) for plating. In addition, the remaining 10% of the transformation mixture was plated on a different plate to obtain countable plates to enumerate bacterial colonies. The plates were transferred to the anaerobic chamber for 3 to 5 days at 35°C after an initial 3 to 5 h of incubation at room temperature.
Identification of positive colonies. All colonies grown on the antibiotic plates were enumerated to determine the transformation efficiency. Ten colonies were randomly selected and inoculated in 1.0 ml of NOS medium for 48 h prior to PCR identification. Bacterial cultures were used as PCR templates to determine the insertion of the antibiotic cassette or integration of genes, the loss of genes such as TDE1430 and TDE0911, and the orientation of insertions by the listed PCR primers that flanked the targeted genes (Table 1) .
SDS-PAGE analysis of bacterial cell lysates. One milliliter of each bacterial culture that was grown to an optical density at 600 nm at 0.4 was harvested by centrifugation and washed three times with phosphate-buffered saline (PBS), and a fraction (1/20) of the cell pellets was boiled in sample loading buffer and used for SDS-12% PAGE analysis, followed by Coomassie blue staining (42) .
Real-time PCR. RNAs were isolated from 2-day cultures of T. denticola by TRIzol reagent according to the manufacturer's protocol (Life Technologies, Carlsbad, CA). A total of 1 g of total DNase-treated RNA was used in a final volume of 20 l for reverse transcription with a Bio-Rad cDNA synthesis kit according to the manufacturer's protocol. Gene expression was evaluated by quantitative real-time PCR with an iCycler (Bio-Rad) using the iScript one-step RT-PCR kit (SYBR green BioRad). The PCR thermal cycling program was used as described by the manufacturer (Life Technologies). Relative quantification was performed according to the ⌬⌬C T method (43) . The expression levels of flgE and flaA were normalized with those for 16S RNA. All primers used in the real-time PCR analysis (RT-flgE-F, RT-flgE-R, RT-flaA-F, RT-flaA-R, RT-TDE16sRNA-F, and RT-TDE16sRNA-R) are listed in Table 1 .
Measurement of colony sizes of T. denticola. Approximately 200 colonies of each strain were plated after serial dilution to 0.8% agarose swarm plates without antibiotics and incubated for 5 days at 35°C. The sizes of the colonies were determined by measuring photographic images with a phase-contrast microscope.
Transmission electron microscopy. Electron microscopy studies were carried out as described previously (44) . In brief, 0.5 ml of a 3-day culture of T. denticola was washed three times with PBS and resuspended in 0.5 ml of PBS containing 1% Triton X-100. The PF of T. denticola were exposed by vortexing. Three additional washings were used to remove the remaining Triton X-100. The final pellet was resuspended in the same volume of PBS, and 10 l of each sample was applied to Formvar carboncoated copper grids (300 mesh; Polysciences, Inc., Warrington, PA). After a 1-min absorption at room temperature, excessive liquid was removed by wicking with filter paper. The grids were then stained with 2% uranyl acetate for 45 s before visualization of T. denticola and the exposed PF using a FEI Tecnai Spirit T12 transmission electron microscope operated at 80 keV (High Resolution Imaging Shared Facility, The University of Alabama at Birmingham, Birmingham, AL).
RESULTS AND DISCUSSION
Screening of antibiotic resistance cassettes for T. denticola 35405. All of the antibiotics available in our lab were used to examine their effectiveness in inhibiting T. denticola (Table 3) . Erythromycin was used as a control since it has been widely used for the genetic manipulation of T. denticola. Similar to erythromycin, six antibiotics were able to inhibit growth of T. denticola except zeocin. Zeocin is usually active aerobically (45) (46) (47) , which may explain why it was not active under the anaerobic condition. To identify effective antibiotic resistance cassettes, genes coding for various antibiotic resistance cassettes, including a chloramphenicol acetyltransferase gene (cat), two kanamycin resistance genes (aphA1 and aphA2), and a gentamicin resistance gene (gat) were first examined in E. coli. These cassettes were cloned into the pGEM-T vector with the promoter from the ermF-ermAM cassette (P1) that is also functional in Porphyromonas gingivalis and Bacteroides spp. (27) . The resulting plasmid constructs were transformed into E. coli XL1-Blue and scored for antibiotic resistance. The chloramphenicol cassette worked well in E. coli. The two kanamycin cassettes also conferred resistance against both kanamycin and G418. However, the gentamicin cassette failed to confer resistance because there was no bacterial growth on the gentamicin plate for cultures that were transformed with the gentamicin cassette (Table 3, 
column 1, E. coli).
To determine whether these cassettes are also functional in T. denticola, the individual cassettes were used to insert into the targeted gene locus TDE1430 and then transformed into E. coli first to determine their antibiotic resistance (Table 3 , column 2, in E. coli). The antibiotic resistance testing revealed that only one kanamycin cassette (aphA2) conferred resistance to kanamycin, whereas E. coli transformed with the TDE1430 allele that was disrupted by the other antibiotic cassettes failed to confer resistance to their corresponding antibiotics. It is not clear why most cassettes under the control of P1 were no longer active in E. coli after insertion into the TDE1430 locus. Furthermore, E. coli transformed with the stand alone aphA2 construct conferred resistance to both kanamycin and G418. However, the aphA2 cassette only exhibited resistance to kanamycin but not to G418 when inserted into the TDE1430 region. Constructs in which the TDE1430 allele was disrupted by various antibiotic cassettes were then transformed into T. denticola. Interestingly, only the allele disrupted by aphA2 gave rise to numerous antibiotic-resistant transformants in T. denticola (Table 3) . Of note, this was the only construct functional in E. coli. This is also true for the previously characterized erythromycin cassette. These observations suggest the functionality of the cassette integrated into the TDE1430 locus in E. coli can be used to predict the utility in T. denticola. This may simplify our efforts to identify more antibiotic resistance cassettes for this difficult organism. It is not clear why only one kanamycin resistance gene (aphA2) worked. The aphA1 gene is derived from the pET-SUMO-28 vector that has been used in other bacteria, whereas the aphA2 cassette from either pGBKT7 (Clontech Laboratories) or pCMV3tag-2 (Agilent Technologies, Santa Clara, CA) has been used in bacteria to confer resistance to kanamycin and mammalian cells to confer resistance to G418. Sequence analysis of these two kanamycin resistance cassettes revealed that they share 35% identity and 52% similarity at the amino acid sequence level; however, only the aphA2 cassette was able to confer resistance to kanamycin in T. denticola, suggesting that a specific sequence is required in T. denticola. The sequences of the gentamicin and chloramphenicol cassettes used in our lab were different from those previously reported that may explain why they were not active in T. denticola despite other reported successes (26, 29, 36, 48) .
The kanamycin cassette is effective in the inactivation of TDE1430. TDE1430 encodes a putative ␤-1,4-galactosyltransferase, albeit its function in T. denticola ATCC 35405 is unclear. TDE1430 was selected to examine the utility of the kanamycin cassette in the allelic replacement mutagenesis for the following reasons. First, our numerous mutagenesis experiments revealed that inactivation of TDE1430 has the highest efficiency compared to our attempts to inactivate other genes such as flgE, TDE1418 (a probable K5 antigen synthesis protein), TDE1427 (a putative glycosyltransferase gene), TDE1441 (a dTDP-glucose 4,6-dehydratase gene), TDE2349 (a flagellar filament gene), TDE1220 (a Treponema-specific hypothetical gene), and TDE0911. Second, TDE1430 is among a few genes that have been inactivated by the transposon mutagenesis (48) . Third, the TDE1430 sequence is resistant to enzymatic digestion by major restriction enzymes in T. denticola. In the genome of T. denticola ATCC 35405, there are three putative type II R-M systems: TDE1268 (TDEI, DpnI), TDE0227/TDE0228 (TDEII, SapI), and TDE0909/TDE0911(TDEIII, Sau96I) that digest exogenous DNA leading to a reduction in transformation efficiency (23, 25) . Interestingly, there is no SapI or Sau96I site in the 5=-and 3=-flanking regions of the TDE1430 locus that avoids restriction digestion by these two major enzyme groups. Only three DpnI sites were found located at the terminus of both the 5=-flanking region and the 3=-flanking region (Fig. 1A) that would not destroy the integrity of the TDE1430 deletion construct. This might explain why the transformation efficiency was high when the TDE1430 constructs were used. Thus, TDE1430 was chosen to evaluate the mutagenesis efficiency of the cassette in T. denticola. The mutagenesis efficiency of the kanamycin cassette was compared to the efficiency obtained with the ermF-ermAM cassette. Evaluation of transformation efficiency using the same batch of competent cells revealed the kanamycin cassette interrupted TDE1430 allele yielded much higher efficiency than the ermF-ermAM cassette-interrupted allele (6-fold) ( Fig. 2A) , demonstrating that the use of the kanamycin cassette is advantageous.
To confirm the genotype of kanamycin-resistant mutants, we carried out PCR studies. Ten kanamycin-resistant T. denticola colonies were selected randomly to evaluate whether they had mutant genotypes. PCR results indicated that all resistant clones contained the kanamycin cassette (Fig. 2Ba) . Furthermore, all resistant clones lost TDE1430 but had TDE1427, a positive control for T. denticola 35405 compared to the wild type (Fig. 2Bb) . PCR using the primer pair flanking TDE1430 revealed the insertion of the kanamycin cassette into the TDE1430 locus ( Fig. 2Bc and d ). These data demonstrate that mutagenesis of TDE1430 using the kanamycin cassette is highly efficient.
The kanamycin cassette without a promoter is also effective in the inactivation of TDE1430. The mutagenesis examined above was carried out using a functional T. denticola promoter to drive the expression of the cassette (Fig. 2Be) . In-frame replacement of genes with an antibiotic cassette is another approach to achieve mutagenesis. The advantage of this approach is that the transcription of the antibiotic resistance gene is driven by the native promoter of the mutant gene. To determine whether the cassette is also active without a fused promoter, we deleted TDE1430 from amino acid residues 1 to 270 and fused the kanamycin cassette aphA2 in-frame with the remaining TDE1430 (Fig. 3Ae) and then carried out transformation in T. denticola using the linearized plasmid construct. Ten resistant colonies were then randomly chosen to determine mutagenesis efficiency. PCR analysis revealed that all 10 kanamycin-resistant clones lost the TDE1430 gene ( Fig. 3Aa) and had the kanamycin cassette inserted in the intended position at the right orientation (Fig. 3Ab, c, and d) , demonstrating the utility of the cassette alone in the mutagenesis of TDE1430.
To further examine whether the kanamycin cassette alone is useful for allelic replacement mutagenesis of other genes, we chose TDE0911 as a target. TDE0911 is a type II restriction enzyme that recognizes Sau96I site; thus, inactivation of TDE0911 would change the restriction digestion pattern of DNA and have an apparent phenotype. TDE0911 was readily inactivated using the kanamycin cassette (Fig. 3Be) . PCR results showed TDE0911 was no longer amplified by TDE0911-specific primers (Fig. 3Ba) ; instead, it was replaced by the kanamycin gene (Fig. 3Bb) . Furthermore, the cassette was inserted into the intended position with the right orientation ( Fig. 3Bc and d) . Phenotypically, inactivation of TDE0911 altered the restriction digestion patterns of the plasmid DNA, pGEM T-Easy-TDE1430-ermF-ermAM (Fig. 3C) . The plasmid linearized by NotI released two bands: pGEM-T Easy (the lower band) and TDE1430-ermF-ermAM (the higher band) (Fig. 3C, lane P) . Treatment of the linearized plasmid with cell lysates of wild-type T. denticola completely eliminated the highermolecular-weight band and concurrently produced a large number of low-molecular-weight bands. In contrast, treatment with cell lysates from 10 TDE0911 mutants failed to abolish the highermolecular-weight band, suggesting the inactivation of TDE0911. These results demonstrated the utility of the kanamycin cassette in the inactivation of TDE0911.
Integration of the full-length flgE gene into the T. denticola flgE mutant genome restored expression of flgE. Because of the existence of the unique restriction and modification system in T. denticola 35405, the strain is extremely difficult to complement by any replicating plasmid. An unmethylated plasmid can be transformed into T. denticola 35405 only when the type II restriction system TDE0911 is inactivated (23) . The chromosomal integration has been used successfully to complement a neuraminidase gene mutant (26) . Here, we attempted to complement the flgE mutant by integrating the flgE gene into the TDE1430 locus. flgE is the gene for the PF hook protein (FlgE). Deletion of flgE led to complete loss of both PF filament and spirochetal motility (30) . Phenotypically, the flgE mutant was nonmotile and no longer swarmed; thus, it was easy to screen if the flgE mutant was complemented and had the ability to translocate and swarm restored when the full-length flgE gene was integrated into the T. denticola chromosome (23, 35) .
Previously, we generated a flgE mutant by using the ermAF cassette (data not shown), and this mutant had all of the known flgE-deficient phenotypes (31), and was used to carry out chromosomal complementation by the allelic replacement of TDE1430 with a construct that contained the kanamycin cassette and the full-length flgE gene. During our trial, we readily inactivated TDE1430 by allelic-replacement mutagenesis regardless of which functional antibiotic cassettes were used. In addition, the inactivation of TDE1430 did not alter any phenotype of T. denticola that we were interested in studying. Therefore, the TDE1430 locus was chosen as a gene integration site for the chromosomal complementation. PCR analysis of obtained kanamycin-resistant clones revealed the loss of TDE1430 (Fig. 4Aa) , the insertion of the kanamycin cassette (Fig. 4Ab) , and the flgE gene (Fig. 4Ac) at the appropriate position and direction of the replacement (Fig. 4Ad) . Genotypically, the deletion of flgE resulted in the loss of expression of flgE. Furthermore, the complementation restored expression of flgE (Fig. 4B) .
Interestingly, deletion of flgE led to an alteration of the protein profile (loss of 38-kDa FlaA and 35-kDa FlaB PF filament proteins) (44, 49) , whereas there was no apparent change in the protein profile when T. denticola TDE1430 was deleted. Complementation of flgE completely restored production of FlaA and FlaB PF filament proteins (Fig. 5A) , suggesting the effectiveness of the chromosomal complementation. However, the FlgE, hook protein monomer, could not be detected. This is likely due to the nature of the FlgE protein. FlgE monomers are covalently linked within the hook structure and usually do not readily dissociate for entry into resolving gels (50) .
Complete recovery of PF and swarming ability when flgE was complemented. Inactivation of TDE1430 did not affect the overall size, PF, or swarming ability of T. denticola. On the other hand, inactivation of flgE altered bacterial shape and size and led to the complete loss of PF. The flgE mutant became elongated and widened and lost the ability to swarm and to maintain a helical shape (31, 32, 35) . Complementation of flgE completely restored the wild-type phenotype (Fig. 5B and C and Fig. 6 ). These results further demonstrated the utility and effectiveness of the kanamycin cassette in the chromosomal complementation.
In summary, the kanamycin cassette we developed is a useful tool for the genetic manipulation of T. denticola 35405. Higher transformation efficiency mediated by the cassette will help us generate mutants by allelic exchange and facilitate the generation of double mutants when combined with the widely used erythromycin cassette. We also demonstrated the successful integration of a full-length gene allele into the spirochetal genome for chromosomal complementation using this cassette, providing a useful alternative to plasmid complementation that has been proven difficult to establish. Chromosomal integration has been demonstrated in the restoration of a TDE0471 mutant by inserting the full-length TDE0471 into the erythromycin resistance cassette on the chromosome of the mutant using a gentamicin antibiotic cassette (26) . Our studies utilized a highly transformable TDE1430 locus to obtain chromosomal complementation. The advantage of our approach is the high transformation efficiency with reproducibility. A disadvantage of this strategy is that the TDE1430 locus was interrupted, which may have unintended side effects when studying bacterial fitness and virulence. This limitation can be overcome by cis-chromosomal complementation. Nevertheless, our studies offer a new and reliable antibiotic cassette to genetically manipulate T. denticola.
